Peripartum Cardiomyopathy: An Atypical Presentation Of COVID-19 Infection
Benouna Mohamed EL Ghali (MD)1, Ech-chenbouli Amine (MD)1, Bendahou Hajar (MD)1 Benmallem Othmane (MD)1, Arous Salim (MD)1, Habbal Rachida (MD)1, Aissaoui Ouissal (MD)2, Salmi Said (MD)2, Barou Lahoucin(MD)2 ,Kettani Chafik (MD)2, Afif Hicham(MD)3
Journal Title:Annals of Case Reports & Reviews
Sars-cov-2 is a pandemic infection by the coronavirus called Covid19. They are more than 3 millions of covid 19 positifs patients with more than 200000 deaths related to this virus till this day, all over the world. PPCM refers to an uncommon form of idiopathic heart failure that occurs during pregnancy or until 5 months postpartum, her association with COVID-19 was never reported until this case. We report a case of 19 years old women who experienced a positive test of COVID-19 associated with peripartum cardiomyopathy 6 days after delivering a twin. Her condition being aggravated she was put on artificial respiration and received a prolactin inhibitor with hydroxycholoroquine associated with azithromycin with a good clinical course. The viral origin of peripartum cardiomyopathy was often raised. This case suggests although the SARS-COV-2 virus may be responsible for myocarditis which is associated with a context of peripartum can be extremely severe.
Keywords: COVID-19, Peripartum cardiomyopathy; hydroxychloroquine.